Atlas Trials

Human Amniotic Epithelial Cells for Asherman's Syndrome

Clinical trial NCT03223454 · UNKNOWN

Trial details

NCT number
NCT03223454
Sponsor
The Second Affiliated Hospital of Chongqing Medical University
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Asherman's Syndrome
Start date
2017-10-01
Primary completion
2019-09-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.